Latest "England Anti Vivisection Society" News Stories

05:39 EDT 18th March 2018 | BioPortfolio

Here are the most relevant search results for "England Anti Vivisection Society" found in our extensive news archives from over 250 global news sources.

More Information about England Anti Vivisection Society on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about England Anti Vivisection Society for you to read. Along with our medical data and news we also list England Anti Vivisection Society Clinical Trials, which are updated daily. BioPortfolio also has a large database of England Anti Vivisection Society Companies for you to search.

Showing "England Anti Vivisection Society" News Articles 1–25 of 5,900+


TeneoBio’s Next Gen Multivalent anti-BCMAxCD3, TNB-383B, and Anti-BCMA UniDabs for CAR T-Cell Therapy of Multiple Myeloma Highlighted at the American Society of Hematology

MENLO PARK, Calif., Dec. 11, 2017 (GLOBE NEWSWIRE) -- TeneoBio, Inc. yesterday presented preclinical data on its lead therapeutic candidate, TNB-383B, a multivalent anti-BCMAxCD3 at the American Society of Hematology annual meeting in Atlanta, Georgia.  The differentiated bispecific molecule uses two anti-BCMA heavy chain variable domains linked to a unique anti-CD3 T-cell recruiting arm tha...

Emergency cancer diagnoses in England fall from in 24% to 20% in 10 years

The way in which cancer is diagnosed in England is showing a slow but steady improvement, according to the latest data published by Public Health England (PHE).1 Cancer survival rates in the UK lag...

How harmful are nano-copper and anti-fungal combinations in the waterways?

(Society of Environmental Toxicology and Chemistry) A recently published article in Environmental Toxicology and Chemistry, 'Effects of Micronized and Nano-Copper Azole on Marine Benthic Communities' explores the risks to the smallest creatures in aquatic communities posed by increased use of the anti-fouling wood treatment.

AI specialists join Genomics England’s drug discovery alliance

Lantern Pharma, a pharma company which uses artificial intelligence (AI) to develop previously-shelved oncology drugs, has joined Genomics England’s groundbreaking industry partnership. First launched in 2012, Genomics England’s 100,000 Genomes Pr...

An improved anti-addiction medication

(American Chemical Society) Drug addiction continues to plague vast numbers of people across the world, destroying and ending lives, while attempts to develop more effective pharmaceutical addiction treatments continue. Scientists now report in the Journal of the American Chemical Society the development of a potent new medicine to fight addiction, which might also be an effective treatment for ep...

Poseida Therapeutics to Present anti-PSMA CAR-T Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene therapy technologies into lifesaving cell therapies, today announced that preclinical data on P-PSMA-101, the company’s PSMA-specific chimeric antigen receptor T cell (CAR-T) stem cell memory drug candidate for the treatment of prostate cancer will...

NHS England faces legal challenges over proposed changes to services

NHS England faces two High Court challenges to its proposed introduction of accountable care organisations (ACOs) in England, both arguing that the move is unlawful.Both legal actions are being...

NHS England consults on curbing OTC prescriptions – PharmaTimes

PharmaTimesNHS England consults on curbing OTC prescriptionsPharmaTimesNHS England has launched a consultation on proposals to cut back on prescriptions for some over the counter products such as dandruff shampoo and drops for tired eyes, in order to garner savings of £136 million. The group says money saved from calling ...Treating dandruff takes millions from vital care, NHS chief Simon Ste...

Vertex negotiating with NHS England on cystic fibrosis drug access

Vertex is trying reach a deal with NHS England to give patients access to all its approved cystic fibrosis (CF) drugs -  and hopes it could also fund further drugs in the pipeline.  The US biotech is in talks with NHS England over a ‘portfolio app...

[News] MSM in England to be offered free HPV vaccination

On Feb 5, 2018, Public Health England (PHE) announced that from April 2018, men who have sex with men (MSM), aged 45 years and younger in England, will be offered free vaccination against human papillomavirus (HPV) infection through their local sexual health clinic.

The Protein Society announces 2018 award recipients

(The Protein Society) The Protein Society, the premier international society dedicated to supporting protein research, announces the winners of the 2018 Protein Society Awards, which will be conferred at their 32nd Annual Symposium (July 9 - 12, 2018, Boston, Massachusetts). Plenary talks from the recipients are scheduled throughout the 3.5-day event.

MS patients in England will have access to Mavenclad thanks to commercial agreement

Patients in England will now have immediate access to the new multiple sclerosis (MS) treatment, cladribine tablets (Mavenclad), thanks to a commercial agreement between the manufacturer, Merck, and NHS England that has been announced today.

Law Schools Shell Out Deep Tuition Discounts to Students

"I was trying to figure out how to swing paying for law school," says the part-time law student, who deferred her acceptance to New England Law Boston for a year. On her LSAT, Shea says she scored higher than most students at New England. The typical LSAT score for a full-time student entering the class in fall 2016 at New England Law was 150, according to survey data reported to U.S. News.

NHS England boss announces ‘benchmark’ Mavenclad deal

Simon Stevens, chief executive of National Health Service (NHS) England, called an access agreement struck…

Researchers identify new anti-inflammatory drug target

A new study suggests that parmodulins may provide anti-inflammatory and anti-thrombotic protection to endothelial cells, without interfering with clotting.

England’s NHS could learn a lot from Scotland

bmj;359/dec08_8/j5703/FAF1faLast year England’s NHS was given high marks for trying to improve standards of care in a report by the Organisation for Economic Co-operation and Development on quality...

NHS England and government are on collision course over funding

Last week NHS England took the unprecedented step of warning that it may be forced to abandon waiting time targets and the implementation of new clinical guidelines next year because of a lack of...

Biophysical Society announces 2018 new and notable symposium speakers

(Biophysical Society) The Biophysical Society has announced the speakers for the New and Notable Symposium at the Society's 62nd Annual Meeting in San Francisco, California. The New and Notable Symposium highlights the latest and most exciting discoveries in biophysics. Speakers are nominated by the Society's membership and selected by the Program Committee two months before the meeting.

U.K. Reverend Sparks Outrage After Telling Christians to Pray for Prince George, 4, to be Gay

Prince George, as future King of England, will one day also be head of the Church of England

Audit shows IVF postcode lottery in England has worsened

Access to IVF in England has worsened considerably over the last five years, according to data obtained by Fertility Fairness...

Why is life expectancy in England and Wales ‘stalling’?

Several independent analyses, by both epidemiologists and actuaries, have concluded that the previous rate of improvement of life expectancy in England and Wales has now slowed markedly, and at older ages may even be reversing. However, although these findings have led the pension industry to reduce estimates of future liabilities, they have failed to elicit […] The post Why is life expectan...

First test of anti-epilepsy surgeries in children shows dramatic benefit

(Reuters Health) - Brain surgery for children whose epilepsy is resistant to drug therapy can produce a 10-fold increase in the odds of being seizure-free after one year and can do it without affecting IQ, according to a new Indian study of 116 patie...

NHS England plans to break down barriers for research

NHS England has announced plans to accelerate the NHS’ national research strategy, cutting bureaucracy and speeding up access to new and innovative treatments. Speaking at the Economist War on Cancer event, NHS Chief Executive Simon Stevens will tell delegates that the NHS is already one of the best places in the world to undertake health research […] The post NHS England plans to break d...

NHS England consults on simplifying research processes

NHS England says it is planning to accelerate the NHS’ national research strategy, “cutting bureaucracy and speeding up access to new and innovative treatments”.

NHS England confirms cull of low-value treatments

Fish oil, herbal remedies and homeopathy are among ‘low-value’ treatments that NHS England is recommending are no longer provided by the NHS, in a move it says should generate millions of pounds of savings each year.

Quick Search


News Quicklinks